XOMA Corp XOMA:NASDAQ

Last Price$17.86NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change+0.09(0.51%)
Bid (Size)$6.23 (3)
Ask (Size)$28.00 (1)
Day Low / High$17.05 - 17.99
Volume66.2 K
 

View Pharmaceuticals: Major IndustryPeer Comparison as of 05/18/2022

 

XOMA Corp ( NASDAQ )

Price: $17.86
Change: +0.09 (0.51%)
Volume: 66.2 K
4:00PM ET 5/18/2022
 
 

Oramed Pharmaceuticals Inc ( NASDAQ )

Price: $4.45
Change: -0.69 (13.42%)
Volume: 17.00
4:00PM ET 5/18/2022
 
 

G1 Therapeutics Inc ( NASDAQ )

Price: $4.63
Change: 0.00 (0.00%)
Volume: 1.6 M
4:00PM ET 5/18/2022
 
 

Omeros Corp ( NASDAQ )

Price: $2.93
Change: -0.19 (6.09%)
Volume: 995.4 K
4:00PM ET 5/18/2022
 
 

Marinus Pharmaceuticals Inc ( NASDAQ )

Price: $5.32
Change: -0.45 (7.80%)
Volume: 232.4 K
4:00PM ET 5/18/2022
 

Read more news Recent News

-- Earnings Flash (XOMA) XOMA CORPORATION Posts Q1 Revenue $3.1M
7:33AM ET 5/05/2022 MT Newswires

...

Insider Sell: Xoma
10:34AM ET 3/24/2022 MT Newswires

James R Neal, Director, CEO, on March 21, 2022, sold 53,450 shares in Xoma (XOMA) for $1,553,807. Following the Form 4 filing with the SEC, Neal has...

-- Earnings Flash (XOMA) XOMA CORPORATION Posts Q4 Revenue $35.9M
7:31AM ET 3/08/2022 MT Newswires

...

XOMA CEO Jim Neal to Retire, Named Chairman of Board; Shares Dip Pre-Bell
8:47AM ET 12/16/2021 MT Newswires

XOMA (XOMA) said Thursday Jim Neal is retiring as CEO of the biotech company and has been named chairman of the board, succeeding W. Denman Van Ness,...

View all Commentary and Analysis

XOMA: First Steps Towards Greatness
9:00AM ET 5/12/2022 Seeking Alpha

XOMA (XOMA) Investor Presentation - Slideshow
12:30PM ET 2/27/2022 Seeking Alpha

Biotech 101 Lecture 1: Intro To Biotechnology Investing
6:35AM ET 2/09/2022 Seeking Alpha

I Put Half Of My Retirement Savings Into These Investments
8:35AM ET 9/02/2021 Seeking Alpha

Company Profile

Business DescriptionXOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA. View company web site for more details
Address2200 Powell Street
Emeryville, California 94608
Phone+1.510.204.7200
Number of Employees11
Recent SEC Filing05/05/202210-Q
Chairman & Chief Executive OfficerJames R. Neal
Chief Financial Officer & Senior VP-FinanceThomas Burns
Investor Relations ContactJuliane Snowden

Company Highlights

Price Open$17.81
Previous Close$17.86
52 Week Range$16.96 - 39.02
Market Capitalization$204.0 M
Shares Outstanding11.4 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings32.47
Earnings per Share$0.57
Beta vs. S&P 500N/A
Revenue$5.3 M
Net Profit Margin29.73%
Return on Equity9.54%

Analyst Ratings as of 03/14/2022

Buy
2
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset